<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Prophylaxis by granulocyte transfusions against <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> associated with <z:hpo ids='HP_0001913'>granulocytopenia</z:hpo> was studied in 69 patients receiving bone-marrow transplants for the therapy of hematologic <z:hpo ids='HP_0002664'>neoplasia</z:hpo> or <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Patients were randomized to receive or not to receive granulocyte transfusions when their circulating granulocyte levels fell to less than 200 per cubic millimeter during the period between transplantation and the development of graft function </plain></SENT>
<SENT sid="2" pm="."><plain>During the first 21 posttransplant days, there were two local <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> and no <z:mpath ids='MPATH_681'>septicemias</z:mpath> in 29 transfused patients </plain></SENT>
<SENT sid="3" pm="."><plain>Seven local <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> and 10 <z:mpath ids='MPATH_681'>septicemias</z:mpath> developed among the 40 controls </plain></SENT>
<SENT sid="4" pm="."><plain>This protection was afforded by granulocytes collected by reversible leukoadhesion as well as by cells collected by continuous-flow centrifugation </plain></SENT>
</text></document>